![Kohei Shitara: Happy to report biomarkers in DESTINIY GC01 at Nature Medicine](https://oncodaily.com/pub/uploads/2024/02/download-23-e1708009528408.jpg)
Photo of Kohei Shitara taken from X/Twitter
May 16, 2024, 09:09
Kohei Shitara: Happy to report biomarkers in DESTINIY GC01 at Nature Medicine
Kohei Shitara, Medical oncologist at National Cancer Center Hospital East, Japan shared a post on X:
“Happy to report biomarkers in DESTINIY GC01 at Nature Medicine. Trastuzumab Deruxtecan (T-DXd), response high if ctDNA+ while still activity observed in negative patients. Response regardless of KRAS, HER2, PIK3CA mutation. Decrease response in other RTKamp+. HER2 loss or topo1mt on PD.”
Further Reading.
Source: Kohei Shitara/X
Jul 2, 2024, 09:57